Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines
Authors:
Open Access
- 1 November 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 86 (2) , 334-341
Abstract
Glomerular mesangial cell proliferation constitutes a frequent pathological alteration in glomerulonephritis. In addition to platelet‐derived growth factor (PDGK) inflammatory cytokines such as IL‐1. IL‐6 or tumour necrosis factor‐alpha (TNF‐α) have been proposed to have mitogenic activity for mesangial cells. A model was therefore established in which human mesangial cells (HMC) could be reversibly growth‐arrested for prolonged times in serum‐free medium without suffering irreversible functional or morphological changes. In this model 24 h stimulation with rhPDGF‐BB induced an increase of the 3H‐thymidine incorporation of 1190.280 (50 ng/ml) %± s.e.m. of medium control. Less growth induction was noted after stimulation with 50 ng ml rhPDGF‐AB (925± I26) or rhPDGF‐AA (575 ± 24%). Northern analysis confirmed the presence of both α and β‐PDGF receptor subunit mRNA in growth‐arrested HMCs. rhlL‐lα, rhlL‐1β, rhTNF‐α or rhIL‐6 at various doses and times, despite increasing cellular PGE2‐release, did not induce significant proliferation in HMCs. Inhibition of PGE2‐release did not change the lack ol mitogenicity of lL‐l, TNF‐α or lL‐6. IL‐6 did not alter the mitogenic response of the cells towards PDGF. In contrast, both IL‐lα and lL‐lβ (5 ng/ml) induced a delay but not augmentation of the PDGF growth response. This delay could be reversed by the concomitant addition or recombinant IL‐6 or of anti‐lL‐1 antibody but not by inhibition of prostaglandin synthesis. High doses of TNF‐α suppressed PDGF‐induced proliferation. These data suggest that in growth‐arrested HMCs inflammatory cytokines have a growth‐modulating or ‐suppressive rather than (co‐)mitogenic effect while PDGF‐BB and‐AB and to a lesser degree PDGF‐AA are potent mitogens. The findings support the notion that the control of HMC proliferation in pathological situations depends on a complex network of interacting stimuli.Keywords
This publication has 39 references indexed in Scilit:
- Recombinant interleukin-1α inhibits the growth of rat mesangial cells in cultureClinical and Experimental Immunology, 1991
- Effect of prostaglandin E2 on proline uptake and protein synthesis by cultured human mesangial cellsKidney International, 1990
- Interleukin 6 is an autocrine growth factor for mesangial cellsKidney International, 1990
- Regulation of human mesangial cell growth in culture by thromboxane A2 and prostacyclinKidney International, 1990
- Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cellsKidney International, 1990
- Preparation of biologically active platelet‐derived growth factor isoforms AA and ABEuropean Journal of Biochemistry, 1990
- Preparation of biologically active platelet-derived growth factor type BB from a fusion protein expressed in EscherichiaBiochemistry, 1989
- Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AAScience, 1989
- Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cellsFEBS Letters, 1988
- Distinguishing minimal-change disease from mesangial disordersKidney International, 1988